Clinical Trials
57 trialsInvestigation of Multi-omics Technique to Predict the Efficacy of Chemoradiotherapy Combined With Immunotherapy for r/m NPC
Sun Yat-sen University
Establishment of a Prospective Clinical Cohort of Small Cell Lung Cancer Patients Receiving Radiotherapy-Involved Comprehensive Treatment
Shanghai Chest Hospital
A Retrospective Clinical Study Exploring Prognostic Factors in Esophageal Cancer Patients
Nanfang Hospital, Southern Medical University
Palliative Thoracic ImmunoRT
University Health Network, Toronto
Remodeling of MHC-related Immune Microenvironment in MIBC After Neoadjuvant Therapy
Cancer Institute and Hospital, Chinese Academy of Medical Sciences
Analyzing Clinical Outcomes and Genomic Data of American Indian Patient Population
University of Oklahoma
COSTAR
Peking University First Hospital
A Study to Evaluate Satisfaction With Care in Patients With Cancer Receiving Immunotherapy Treatment at Home
Bristol-Myers Squibb
Adjuvant Radioimmunotherapy Compared With Adjuvant Chemotherapy for UTUC
Peking University First Hospital
A Study on the Heterogeneity of Efficacy of Interventional Therapy Combined With Systemic Therapy for Liver Cancer Based on Multi-center Real-world Data
The First Affiliated Hospital of Zhengzhou University
ARIS
Hopitaux Prives de Metz, Groupe UNEOS
A Benefit Population Atlas of nICT Versus nCT for LAGC
Jiangsu Cancer Institute & Hospital
PRISMM
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
AGAMENON
Fundación Sociedad Española de Oncologia Médica
Efficacy and Safety of Chemoimmunotherapy and Carbon Ion Radiotherapy in Unresectable Locally Advanced Non-small Cell Lung Cancer
Zhejiang Cancer Hospital
Cardiopulmonary Monitoring in Lung Cancer Patients Receiving Combined Thoracic Radiotherapy and Immunotherapy
University of Missouri-Columbia
Molecular Analysis and Treatment Options of Thymic Malignancies
Shanghai Chest Hospital
Life-Score
Shanghai Chest Hospital
A Multicenter Registry Study on Stage III Hepatocellular Carcinoma in Unresectable CNLC Liver Cancer
Fudan University
FECONDE
IRCCS San Raffaele
C-MSI
Gruppo Oncologico Italiano di Ricerca Clinica
BTCICTY-001
Zhongda Hospital
HEFTME System for Adjuvant Therapeutic Selection of Locally Advanced UTUC Postoperatively:A Perspective Cohort Study
Peking University First Hospital
AI-HOPE Lung Cancer: Building a Predictive Tool for Metastatic Lung Cancer
IRCCS San Raffaele
ROOT
Taproot Health
Molecular Analysis and Treatment Options of SCLC
Shanghai Chest Hospital
APiTOXMM
University Hospital, Montpellier
MINING
Washington University School of Medicine
HIBIC-NSCLC
The First People's Hospital of Neijiang
Organoid Model Predictive of Response to Immunotherapies
Indiana University
A Study to Prospectively Validate Blood Markers Associated With Differences in Efficacy of Neoadjuvant Therapy for NSCLC
Tang-Du Hospital
Relation Between Tumor-draining Lymph Nodes Metastasis Pattern and Non-small Cell Lung Cancer Neoadjuvant Immunotherapy Effectiveness
Sun Yat-sen University
ARGONAUT: Stool and Blood Sample Bank for Cancer Patients
Persephone Biosciences
Differences in Rate of Decline in CT-defined Skeletal Muscle Mass and Physical Performance in Patients With Advanced Non-small Cell Lung Cancer Receiving Chemotherapy and Targeted Therapy/Immunotherapy, Before and After Treatment.
Prince of Songkla University
Combined Statin and PD-1/PD-L1 Inhibitors in Treating Non-small Cell Lung Cancer
The Fourth Affiliated Hospital of Zhejiang University School of Medicine
The Predictive Biomarkers in Patients With Locally Advanced Non-small Cell Lung Cancer
Cancer Institute and Hospital, Chinese Academy of Medical Sciences
RECSUR
Erasmus Medical Center
REICRAE
Tianjin Medical University Cancer Institute and Hospital
A Retrospective Study on the Treatment of Intermediate and Advanced Liver Cancer.
Qianfoshan Hospital
CAREMM-2305
Seoul St. Mary's Hospital
CAREMM-2306: Advanced Immunotherapy vs. Classical Immunotherapy
Seoul St. Mary's Hospital
TREATMENT
Oslo University Hospital
Chemotherapy and Tislelizumab With Split-course HFRT for Locally Advanced Rectal Cancer
Fujian Medical University Union Hospital
IPRICE
Institut de cancérologie Strasbourg Europe
I-STOP
University of Milano Bicocca
Real-world Study for Patients With Advanced Hepatobiliary Tumors
Peking Union Medical College Hospital
G-DEFINER
Fondazione IRCCS Istituto Nazionale dei Tumori, Milano
QUASAR
University of California, San Diego
RECORD
Chinese PLA General Hospital
DreaminLMBC
Zhejiang Cancer Hospital